• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Letter to the Editor: Commentary on "Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients".致编辑的信：关于“证据足够了吗？：坦索罗辛0.2毫克和坦索罗辛0.4毫克作为亚洲良性前列腺增生患者初始治疗剂量疗效的系统评价和网络荟萃分析”的评论
Int Neurourol J. 2017 Sep;21(3):229-230. doi: 10.5213/inj.1734962.481. Epub 2017 Sep 12.
2
Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients.证据是否足够？：坦索罗辛0.2毫克和坦索罗辛0.4毫克作为亚洲良性前列腺增生患者初始治疗剂量疗效的系统评价和网状Meta分析
Int Neurourol J. 2017 Mar 24;21(1):29-37. doi: 10.5213/inj.1734826.413.
3
The Authors Reply: Reply on "Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients".作者回复：对“证据足够吗？：坦索罗辛0.2毫克和坦索罗辛0.4毫克作为亚洲良性前列腺增生患者初始治疗剂量疗效的系统评价和网络荟萃分析”的回复。
Int Neurourol J. 2017 Sep;21(3):231-232. doi: 10.5213/inj.1734986.493. Epub 2017 Sep 12.
4
General effect of low-dose tamsulosin (0.2 mg) as a first-line treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia: a systematic review and meta-analysis.低剂量坦索罗辛（0.2毫克）作为良性前列腺增生相关下尿路症状一线治疗的总体效果：一项系统评价和荟萃分析
Curr Med Res Opin. 2015 Feb;31(2):353-65. doi: 10.1185/03007995.2014.980887. Epub 2014 Nov 7.
5
Meta-analysis of the efficacy and safety of combination of tamsulosin plus dutasteride compared with tamsulosin monotherapy in treating benign prostatic hyperplasia.坦索罗辛联合度他雄胺与坦索罗辛单药治疗良性前列腺增生的疗效和安全性的荟萃分析。
BMC Urol. 2019 Mar 11;19(1):17. doi: 10.1186/s12894-019-0446-8.
6
Meta-Analysis of Efficacy and Safety of Tadalafil Plus Tamsulosin Compared with Tadalafil Alone in Treating Men with Benign Prostatic Hyperplasia and Erectile Dysfunction.坦索罗辛联合他达拉非对比他达拉非单药治疗前列腺增生伴勃起功能障碍的疗效和安全性的 Meta 分析。
Am J Mens Health. 2019 Sep-Oct;13(5):1557988319882597. doi: 10.1177/1557988319882597.
7
Effectiveness of the addition of tadalafil to tamsulosin in the treatment of acute urinary retention in patients with benign prostatic hyperplasia: A randomized clinical trial.他达拉非联合坦索罗辛治疗良性前列腺增生患者急性尿潴留的有效性：一项随机临床试验。
Urologia. 2018 May;85(2):51-54. doi: 10.1177/0391560317749427. Epub 2018 Mar 26.
8
Efficacy and safety of tamsulosin in the treatment of benign prostatic hyperplasia.
Med Arch. 2012;66(3):173-6. doi: 10.5455/medarh.2012.66.173-176.
9
Beneficial Effect of Increasing the Dose of Tamsulosin to 0.4 mg in Japanese Patients with Benign Prostatic Hyperplasia.增加坦索罗辛剂量至0.4毫克对日本良性前列腺增生患者的有益作用。
J Rural Med. 2011;6(2):60-4. doi: 10.2185/jrm.6.60. Epub 2011 Dec 7.
10
Tamsulosin for the treatment of benign prostatic hypertrophy.坦索罗辛用于治疗良性前列腺增生。
Ann Pharmacother. 2000 Feb;34(2):188-99. doi: 10.1345/aph.18263.

引用本文的文献

1
The Authors Reply: Reply on "Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients".作者回复：对“证据足够吗？：坦索罗辛0.2毫克和坦索罗辛0.4毫克作为亚洲良性前列腺增生患者初始治疗剂量疗效的系统评价和网络荟萃分析”的回复。
Int Neurourol J. 2017 Sep;21(3):231-232. doi: 10.5213/inj.1734986.493. Epub 2017 Sep 12.

本文引用的文献

1
Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients.证据是否足够？：坦索罗辛0.2毫克和坦索罗辛0.4毫克作为亚洲良性前列腺增生患者初始治疗剂量疗效的系统评价和网状Meta分析
Int Neurourol J. 2017 Mar 24;21(1):29-37. doi: 10.5213/inj.1734826.413.
2
A century of trends in adult human height.成年人身高的百年趋势
Elife. 2016 Jul 26;5:e13410. doi: 10.7554/eLife.13410.
3
Efficacy of Dose Escalation of Tamsulosin for the Treatment of Lower Urinary Tract Symptoms.坦索罗辛剂量递增治疗下尿路症状的疗效
Low Urin Tract Symptoms. 2012 May;4(2):96-102. doi: 10.1111/j.1757-5672.2012.00141.x. Epub 2012 Feb 17.
4
Assessment of Tamsulosin 0.2 mg for Symptomatic Bladder Outlet Obstruction Secondary to Benign Prostatic Enlargement: Data from a Korean Multicenter Cross-Sectional Study.
Urol Int. 2015;95(1):50-5. doi: 10.1159/000366007. Epub 2015 Apr 22.
5
Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group.α1受体阻滞剂YM617在良性前列腺增生治疗中的应用。YM617临床研究组。
J Urol. 1990 Oct;144(4):908-11; discussion 911-2. doi: 10.1016/s0022-5347(17)39620-9.

Letter to the Editor: Commentary on "Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients".

作者信息

Tae Bum Sik, Choi Hoon, Bae Jae Hyun

机构信息

Department of Urology, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.

出版信息

Int Neurourol J. 2017 Sep;21(3):229-230. doi: 10.5213/inj.1734962.481. Epub 2017 Sep 12.

DOI:10.5213/inj.1734962.481
PMID:28954466
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5636962/
Abstract
摘要